Growth Metrics

Fulgent Genetics (FLGT) Other financing activities (2016 - 2026)

Fulgent Genetics' Other financing activities history spans 9 years, with the latest figure at $4.2 million for Q1 2026.

  • On a quarterly basis, Other financing activities rose 122.58% to $4.2 million in Q1 2026 year-over-year; TTM through Mar 2026 was $5.3 million, a 72.33% increase, with the full-year FY2025 number at $3.0 million, up 4.73% from a year prior.
  • Other financing activities hit $4.2 million in Q1 2026 for Fulgent Genetics, up from $447000.0 in the prior quarter.
  • Over the last five years, Other financing activities for FLGT hit a ceiling of $4.2 million in Q1 2026 and a floor of $232000.0 in Q2 2023.
  • Historically, Other financing activities has averaged $860882.4 across 5 years, with a median of $494000.0 in 2022.
  • The widest YoY moves for Other financing activities: up 1017.95% in 2022, down 92.38% in 2022.
  • Tracing FLGT's Other financing activities over 5 years: stood at $316000.0 in 2022, then surged by 252.53% to $1.1 million in 2023, then tumbled by 78.28% to $242000.0 in 2024, then surged by 84.71% to $447000.0 in 2025, then soared by 839.6% to $4.2 million in 2026.
  • Business Quant data shows Other financing activities for FLGT at $4.2 million in Q1 2026, $447000.0 in Q4 2025, and $357000.0 in Q3 2025.